Modular Manufacturing Innovations Win Industry Awards
Pharmaceutical operators can learn from these award-winning modular designs to improve production agility and energy efficiency.
Updated on Oct. 31, 2026 in Healthcare
Live Poll
Do you believe pharmaceutical companies are doing enough to prioritize sustainability in their manufacturing processes?
The International Society for Pharmaceutical Engineering (ISPE) presented its 2026 Facility of the Year Awards, highlighting innovations in modular manufacturing and automation across the global pharmaceutical industry. The awards showcase new facility designs and operational strategies that major manufacturers are adopting to improve efficiency and scale.
Why it matters
These awards provide a benchmark for how top-tier pharmaceutical manufacturers are utilizing modular design and autonomous systems to reduce production costs and environmental impact. For operational leaders, these designs represent emerging industry standards in agile, high-capacity manufacturing.
Award-winning projects demonstrated significant operational efficiency, including an 80% CO2 emission reduction and 1,600 tons of annual CO2 savings via Takeda's Project AHEAD. These metrics serve as new benchmarks for pharmaceutical manufacturers optimizing facility footprint.
The players
Sanofi
A global healthcare company focused on the development and manufacturing of innovative therapeutic solutions.
Bayer
A multinational pharmaceutical and life sciences company with a heavy focus on digital manufacturing integration.
Eli Lilly and Company
A research-driven pharmaceutical leader focused on scaling complex drug manufacturing through advanced project execution.
AstraZeneca
A global biopharmaceutical firm that develops and distributes specialized medicines to address critical unmet medical needs.
Takeda
A research-based global biopharmaceutical company prioritizing sustainable manufacturing and carbon-reduction initiatives.
The details
Winning facilities utilized highly specific technical strategies to achieve operational gains, such as the use of inflatable, movable walls in Sanofi's Modulus facilities to reconfigure production bays. Bayer's SOLIDA-1 facility leveraged automated modular lines and customized robotics to facilitate autonomous formulation, while Takeda's Project AHEAD integrated high-temperature steam systems to lower the facility carbon footprint. These projects prioritize physical flexibility and digital automation to shorten supply chain cycles.
Timeline
June 2022 marked the groundbreaking for the Eli Lilly Concord site.
December 2024 saw the FDA approval for the Eli Lilly Concord site.
2026 marked the presentation of the ISPE Facility of the Year Awards.
December 7, 2026 is the submission deadline for the 2027 FOYA awards.
Market Landscape
These projects illustrate a sector-wide pivot toward Pharma 4.0, which prioritizes digitized, autonomous manufacturing to achieve long-term operational excellence. This shift marks a departure from traditional, fixed-line production in favor of modular, reconfigurable facility architectures.
Manufacturers should evaluate the scalability of modular reconfigurable walls and autonomous robotics to reduce their own facility downtime and energy overhead. Benchmarking against these 2026 winners provides a clear roadmap for digitizing production lines to meet future regulatory and sustainability targets.
The takeaway
The modular manufacturing movement is no longer experimental, as evidenced by the integration of inflatable production bays and robotic automation at scale. Operators should track the project execution timelines of these winners to gauge how quickly modular upgrades can move from groundbreaking to regulatory compliance.
What happens next
Operators interested in participating in the next cycle must submit their project applications by December 7, 2026.
Further reading
Explore industry trends and manufacturing standards in our Healthcare section.
Source note: This article includes information reported by Pharmaceuticalonline.
Live Poll
Do you believe pharmaceutical companies are doing enough to prioritize sustainability in their manufacturing processes?
